JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265820

Human PI4K2A knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

PI4K2A KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and 2 bp deletion in exon 1. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.
2 Images
Sanger Sequencing - Human PI4K2A knockout HeLa cell line (AB265820)
  • Sanger seq

Unknown

Sanger Sequencing - Human PI4K2A knockout HeLa cell line (AB265820)

Allele-2 : 1 bp deletion in exon 1.

Sanger Sequencing - Human PI4K2A knockout HeLa cell line (AB265820)
  • Sanger seq

Unknown

Sanger Sequencing - Human PI4K2A knockout HeLa cell line (AB265820)

Allele-1 : 2 bp deletion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon 1 and 2 bp deletion in exon 1

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265820-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265820-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265820 Human PI4K2A knockout HeLa cell line", "number":"AB265820-CMP01" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265820-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265820-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265820 Human PI4K2A knockout HeLa cell line", "number":"AB265820-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265820-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265820 Human PI4K2A knockout HeLa cell line", "number":"AB265820-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265820-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265820 Human PI4K2A knockout HeLa cell line", "number":"AB265820-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
PI4K2A
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Quality control - STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PI4K2A also known as phosphatidylinositol 4-kinase type 2 alpha is an enzyme involved in phospholipid signaling. It catalyzes the phosphorylation of phosphatidylinositol (PI) to generate phosphatidylinositol 4-phosphate (PI4P). This enzyme is part of the PI4K family and typically has a mass of approximately 55 kDa. PI4K2A is primarily expressed in brain tissue but can also be found in other tissues such as heart and liver.
Biological function summary

PI4K2A plays a significant role in cellular processes through its involvement in phosphoinositide turnover. It contributes to the synthesis of membrane phospholipids and helps regulate vesicle trafficking. PI4K2A functions as part of larger protein complexes involved in generating PI4P a precursor for producing phosphatidylinositol 45-bisphosphate (PI(45)P2) which is critical for various signaling pathways.

Pathways

PI4K2A associates with the phosphoinositide signaling pathway and the endocytic pathway. In the phosphoinositide signaling pathway it interacts with other kinases to facilitate the production of PI4P and PI(45)P2 which serve as signaling molecules. Within these pathways PI4K2A collaborates with proteins like PI4KB to regulate membrane dynamics and endocytosis.

PI4K2A has connections to neurodegenerative diseases and some cardiovascular conditions. Abnormal PI4K2A expression or function may disrupt phosphoinositide balance affecting cellular signaling and leading to disease. It relates to the LRRK2 protein in Parkinson's disease where dysregulated PI4P levels have implications for disease progression. Furthermore in cardiovascular disorders altered PI4K2A activity may impact heart muscle functionality contributing to disease development.

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability. <p>1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.<br>2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.<br>3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.<br>4. Incubate the culture at 37°C incubator with 5% CO<sub>2</sub>. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.<br>5. Once confluent passage into an appropriate flask at a density of 2x10<sup>4</sup> cells/cm<sup>2</sup>. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.</p>

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com